Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telbivudine and Lamivudine for HBV Transmission Prevention
NCT01743079Phase 4Completed
- Sponsor
- Beijing YouAn Hospital
- Start
- Jan 2009
- Primary completion
- Jul 2013
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of telbivudine, lamivudine in hepatitis B (HBV), sponsored by Beijing YouAn Hospital. Started Jan 2009; status: completed.
02
Drugs
telbivudinelamivudine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT01743079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01743079.